tailieunhanh - Prognostic prediction of glioblastoma by quantitative assessment of the methylation status of the entire MGMT promoter region

O6-methylguanine-DNA methyltransferase (MGMT) promoter methylation is reported to be a prognostic and predictive factor of alkylating chemotherapy for glioblastoma patients. Methylation specific PCR (MSP) has been most commonly used when the methylation status of MGMT is assessed. |

TÀI LIỆU LIÊN QUAN
TỪ KHÓA LIÊN QUAN